Health & Biotech
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on Starpharma.
RELATED STOCKHEAD STORIES
Health & Biotech
ASX Health Stocks: Imugene begins Phase 1 trial of its cancer-fighting virus
Health & Biotech
ASX Health Stocks: UK FSA welcomes Cann’s CBD capsules onto its approved list
Health & Biotech
ASX Health Stocks: OncoSil up 15pc on German device funding; Starpharma expands to Middle East
Health & Biotech
ASX Health Stocks: Neuren stock price up 100pc on positive Phase 3 results
Health & Biotech
ASX Health Stocks: Alcidion wins Aussie government contract, while Resonance seeks US FDA nod
Health & Biotech
ASX Health Stocks: After TGA approval in Australia, Telix now gets license to sell in Brazil
Health & Biotech
ASX Health Stocks: Rhythm Biosciences scores CE Mark approval, shares jump
Health & Biotech
ASX Health Stocks: Biotron gets a boost with promising in vivo study for COVID-19 treatment
Health & Biotech
ASX Health Stocks: Resapp gains on India COVID-19 trial, Atomo to supply HIV self-test in Australia
Health & Biotech
ASX Health Stocks: Immuron jumps 19pc after lead COVID-19 drug benefits published in major journal
News
Closing Bell: ASX 200 down two consecutive days as small caps get pummelled
Health & Biotech
ASX Health Stocks: Osprey jumps 8% on solid first half; Bard1 concludes successful study
News
Here are the Top 25 ASX large cap movers for Tuesday
News
Closing Bell: ASX 200 continues to soar as Japara set to agree to takeover deal
Health & Biotech
ScoPo’s Powerplays: Buying opportunities in a volatile week
News
Last Orders: Tech leads the ASX 200 to finish just over the line
News
